Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2008

01-04-2008 | Case Report

Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer

Authors: Satoshi Hashino, Sumiko Kobayashi, Mutsumi Takahata, Masahiro Onozawa, Masao Nakagawa, Takahito Kawamura, Fumie Fujisawa, Koh Izumiyama, Kaoru Kahata, Takeshi Kondo, Masahiro Asaka

Published in: International Journal of Clinical Oncology | Issue 2/2008

Login to get access
Metadata
Title
Graft-versus-tumor effect after reduced-intensity allogeneic hematopoietic stem cell transplantation in a patient with advanced colon cancer
Authors
Satoshi Hashino
Sumiko Kobayashi
Mutsumi Takahata
Masahiro Onozawa
Masao Nakagawa
Takahito Kawamura
Fumie Fujisawa
Koh Izumiyama
Kaoru Kahata
Takeshi Kondo
Masahiro Asaka
Publication date
01-04-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-007-0716-4

Other articles of this Issue 2/2008

International Journal of Clinical Oncology 2/2008 Go to the issue

Review Article

The role of cancer registries in cancer control

Original Article

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

Review Article

A history of the cancer registration system in Japan

From the Asco-Jsco Joint Symposium

Current status of chemoradiotherapy for gastric cancer in Japan

Review Article

Current activities and future directions of the cancer registration system in Japan

Original Article

Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits